ICICI Direct has buy call on with a target price of Rs 1165. The current market price of Aurobindo Pharma Ltd. is Rs 924.5.
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 53897.56 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 6498.31 Crore, down -.59 % from last quarter Total Income of Rs 6537.19 Crore and up 9.66 % from last year same quarter Total Income of Rs 5925.93 Crore. Company reported net profit after tax of Rs 2960.78 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 51.9 per cent stake in the company as of Dec 30, 2020, while FIIs held 25 per cent, DIIs 12.6 per cent and public and others 10.5 per cent.
